First ready-to-use liquid glucagon available in a single-dose vial and syringe kit for rescue
Gvoke HypoPen®, Gvoke® PFS, and Gvoke® Kit – three different administration options to accommodate patients’ preferences
Gvoke Kit eliminates the need for reconstitution
Gvoke Kit availability anticipated in early Q1 2022
https://finance.yahoo.com/news/xeris-pharmaceuticals-announces-approval-supplemental-120000266.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.